Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Dec 1;15(5):665–674.e5. doi: 10.1016/j.cgh.2016.11.025

Table 2.

Ulcerative-colitis and dysplasia-related risk factors associated with progression of dysplasia in patients with low-grade dysplasia.

Outcome Number of studies Pooled OR with CI 65% P value
Ulcerative colitis-related characteristics
Age at LGD diagnosis (per unit) 3 0.99 (0.96-1.02) 0.53
Age at UC diagnosis (per unit) 2 1.00 (0.96-1.03) 0.86
Disease Duration (per unit) 3 0.99 (0.96-1.02) 0.42
Male Sex 2 1.10 (0.57-2.12) 0.77
Concomitant PSC 3 3.42 (1.51-7.78) <0.01
Dysplasia-related characteristics
Invisible dysplasia (vs visible dysplasia) 6 1.87 (1.04-3.36) 0.04
Distal location (vs proximal) 4 2.01 (1.10-3.65) 0.02
Multifocal dysplasia 3 3.54 (1.47-8.52) <0.01
Persistent dysplasia (vs. Incident LGD) 2 1.36 (0.56-3.31) 0.50

Abbreviations: LGD, Low-grade dysplasia; OR, Odds ratio; PSC, Primary sclerosing cholangitis; UC, Ulcerative colitis